T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Harmony Biosciences
HRMY
$2.24B
| $444K | ﹤0.01% |
14,692
+473
| +3% | +$14.2K |
|
2227
Maravai LifeSciences
MRVI
$861M
| $443K | ﹤0.01% |
61,863
-11,732
| -16% | -$101K |
|
2228
American Vanguard Corp
AVD
$62.8M
| $442K | ﹤0.01% |
51,388
+623
| +1% | +$6.37K |
|
2229
LendingTree
TREE
$461M
| $442K | ﹤0.01% |
10,616
-5,836
| -35% | -$246K |
|
2230
FB Financial Corp
FBK
$3.1B
| $441K | ﹤0.01% |
11,297
+1,151
| +11% | +$42.6K |
|
2231
Healthcare Services Group
HCSG
$1.45B
| $441K | ﹤0.01% |
41,629
+1,799
| +5% | +$20K |
|
2232
Orthofix Medical
OFIX
$415M
| $441K | ﹤0.01% |
33,249
+292
| +0.9% | +$4K |
|
2233
Fluence Energy
FLNC
$2.44B
| $439K | ﹤0.01% |
25,266
+2,577
| +11% | +$49.5K |
|
2234
Lemonade
LMND
$4.1B
| $438K | ﹤0.01% |
26,511
+1,902
| +8% | +$31.7K |
|
2235
Hippo Holdings
HIPO
$869M
| $436K | ﹤0.01% |
25,334
+2,006
| +9% | +$38K |
|
2236
Kearny Financial
KRNY
$604M
| $436K | ﹤0.01% |
70,851
| – | – |
|
|
TRUE
2237
DELISTED
TrueCar
TRUE
| $435K | ﹤0.01% |
138,660
+16,476
| +13% | +$48.3K |
|
2238
Levi Strauss
LEVI
$8.63B
| $430K | ﹤0.01% |
22,302
+4,800
| +27% | +$105K |
|
|
FLNA
2239
Filana Therapeutics
FLNA
$45.7M
| $430K | ﹤0.01% |
34,784
+3,457
| +11% | +$72.9K |
|
2240
Arcturus Therapeutics
ARCT
$223M
| $429K | ﹤0.01% |
17,617
+613
| +4% | +$18.6K |
|
2241
Goosehead Insurance
GSHD
$2.39B
| $429K | ﹤0.01% |
7,452
+1,300
| +21% | +$78K |
|
|
REFI
2242
Chicago Atlantic Real Estate Finance
REFI
$264M
| $428K | ﹤0.01% |
27,805
+4,700
| +20% | +$73.5K |
|
2243
Powell Industries
POWL
$7.43B
| $427K | ﹤0.01% |
8,913
+1,023
| +13% | +$53.4K |
|
2244
AMC Global Media
AMCX
$496M
| $426K | ﹤0.01% |
44,054
+1,243
| +3% | +$16.4K |
|
|
NVEE
2245
DELISTED
NV5 Global
NVEE
| $423K | ﹤0.01% |
18,160
+2,272
| +14% | +$53K |
|
2246
AvePoint
AVPT
$2.91B
| $420K | ﹤0.01% |
40,273
-2,191
| -5% | -$19K |
|
2247
Liquidity Services
LQDT
$1.35B
| $420K | ﹤0.01% |
21,015
+121
| +0.6% | +$2.26K |
|
2248
Turning Point Brands
TPB
$1.73B
| $420K | ﹤0.01% |
13,084
+447
| +4% | +$13.8K |
|
2249
Sprinklr
CXM
$1.65B
| $419K | ﹤0.01% |
43,489
+2,310
| +6% | +$25.8K |
|
|
TDAY
2250
USA Today Co
TDAY
$1B
| $419K | ﹤0.01% |
90,805
+2,437
| +3% | +$8.15K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.